186 related articles for article (PubMed ID: 10931589)
21. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
Kim SK; Kim SH; Lee WJ; Kim H; Seo JW; Choi D; Lim HK; Lee SJ; Lim JH
AJR Am J Roentgenol; 2002 Sep; 179(3):741-50. PubMed ID: 12185056
[TBL] [Abstract][Full Text] [Related]
22. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
23. Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
De Filippo M; Bocchi C; Quartieri L; Corradi D; Zompatori M
Acta Biomed; 2007 Dec; 78(3):225-8. PubMed ID: 18330084
[TBL] [Abstract][Full Text] [Related]
24. Sequence optimization in mangafodipir trisodium-enhanced liver and pancreas MRI.
Wang C; Johansson L; Western A; Fagertun H; Ahlström H
J Magn Reson Imaging; 1999 Feb; 9(2):280-4. PubMed ID: 10077025
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
[TBL] [Abstract][Full Text] [Related]
26. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Kim MJ; Kim JH; Lim JS; Oh YT; Chung JJ; Choi JS; Lee WJ; Kim KW
J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
[TBL] [Abstract][Full Text] [Related]
27. [Detection of liver metastases in colorectal cancer on chemotherapy. Comparative study between MRI with teslascan and computed tomography with intravenous contrast media].
Beziat C; Pilleul F; Yzebe D; Lombard-Bohas C; Mercier C; Valette PJ
J Radiol; 2004 Mar; 85(3):307-11. PubMed ID: 15192523
[TBL] [Abstract][Full Text] [Related]
28. [MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation].
Dobritz M; Fellner FA; Baum U; Nömayr A; Lell M; Klein P; Papadopoulos T; Bautz W
Rofo; 2002 Jul; 174(7):893-7. PubMed ID: 12101481
[TBL] [Abstract][Full Text] [Related]
29. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P
Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926
[TBL] [Abstract][Full Text] [Related]
30. Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients.
Vitellas KM; El-Dieb A; Vaswani KK; Bennett WF; Fromkes J; Ellison C; Bova JG
AJR Am J Roentgenol; 2002 Aug; 179(2):409-16. PubMed ID: 12130442
[TBL] [Abstract][Full Text] [Related]
31. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
Oudkerk M; Torres CG; Song B; König M; Grimm J; Fernandez-Cuadrado J; Op de Beeck B; Marquardt M; van Dijk P; de Groot JC
Radiology; 2002 May; 223(2):517-24. PubMed ID: 11997562
[TBL] [Abstract][Full Text] [Related]
32. Uptake of mangafodipir trisodium in liver metastases from endocrine tumors.
Wang C; Ahlström H; Eriksson B; Lönnemark M; McGill S; Hemmingsson A
J Magn Reson Imaging; 1998; 8(3):682-6. PubMed ID: 9626886
[TBL] [Abstract][Full Text] [Related]
33. Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability.
Mann GN; Marx HF; Lai LL; Wagman LD
Ann Surg Oncol; 2001 Aug; 8(7):573-9. PubMed ID: 11508618
[TBL] [Abstract][Full Text] [Related]
34. Diagnosing biliary complications of orthotopic liver transplantation with mangafodipir trisodium-enhanced MR cholangiography: comparison with conventional MR cholangiography.
Bridges MD; May GR; Harnois DM
AJR Am J Roentgenol; 2004 Jun; 182(6):1497-504. PubMed ID: 15149996
[TBL] [Abstract][Full Text] [Related]
35. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
Braga HJ; Choti MA; Lee VS; Paulson EK; Siegelman ES; Bluemke DA
Radiology; 2002 May; 223(2):525-31. PubMed ID: 11997563
[TBL] [Abstract][Full Text] [Related]
36. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Bartolozzi C; Donati F; Cioni D; Procacci C; Morana G; Chiesa A; Grazioli L; Cittadini G; Cittadini G; Giovagnoni A; Gandini G; Maass J; Lencioni R
Eur Radiol; 2004 Jan; 14(1):14-20. PubMed ID: 14730384
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory pseudotumor of the liver: MRI with mangafodipir trisodium.
Materne R; Van Beers BE; Gigot JF; Horsmans Y; Lacrosse M; Pringot J
J Comput Assist Tomogr; 1998; 22(1):82-4. PubMed ID: 9448766
[TBL] [Abstract][Full Text] [Related]
38. Improved image contrast with mangafodipir trisodium (MnDPDP) during MR-guided percutaneous cryosurgery of the liver.
Traoré AS; Godbout MJ; Serre D; Younan R; Dionne G; Dufour M; Morin J; Moisan C
Magn Reson Imaging; 2003 Jul; 21(6):609-15. PubMed ID: 12915191
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
Federle M; Chezmar J; Rubin DL; Weinreb J; Freeny P; Schmiedl UP; Brown JJ; Borrello JA; Lee JK; Semelka RC; Mattrey R; Dachman AH; Saini S; Harms SE; Mitchell DG; Anderson MW; Halford HH; Bennett WF; Young SW; Rifkin M; Gay SB; Ballerini R; Sherwin PF; Robison RO
J Magn Reson Imaging; 2000 Nov; 12(5):689-701. PubMed ID: 11050638
[TBL] [Abstract][Full Text] [Related]
40. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
Youk JH; Lee JM; Kim CS
AJR Am J Roentgenol; 2004 Oct; 183(4):1049-54. PubMed ID: 15385303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
